Gilead Sciences, Inc. Website

Gilead Sciences, Inc.

NasdaqGS-GILD

Income Statement
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
LTM

Total Revenues

22,449

24,689

27,305

27,281

27,116

27,805

Total Revenues % Chg.

1.5%

10%

10.6%

-0.1%

-0.6%

1.5%

Cost of Goods Sold, Total

4,675

3,691

5,526

5,657

6,019

6,272

Gross Profit

17,774

20,998

21,779

21,624

21,097

21,533

Selling General & Admin Expenses, Total

4,381

5,112

5,246

5,673

5,537

5,099

R&D Expenses

4,055

4,927

4,601

4,998

5,758

5,728

Other Operating Expenses, Total

8,436

10,039

9,847

10,671

11,295

10,827

Operating Income

9,338

10,959

11,932

10,953

9,802

10,706

Interest Expense, Total

-995

-984

-1,001

-935

-944

-976

Interest And Investment Income

—

—

—

—

—

—

—

—

376

376

352

Net Interest Expenses

-995

-984

-1,001

-559

-568

-624

Currency Exchange Gains (Loss)

22

—

-23

-21

-21

-6

Other Non Operating Income (Expenses)

605

244

-6

-279

11

-4

EBT, Excl. Unusual Items

8,970

10,219

10,902

10,094

9,224

10,072

Restructuring Charges

—

—

—

—

—

—

—

—

—

-527

-612

Merger & Related Restructuring Charges

—

—

—

—

—

—

-920

—

—

—

—

Gain (Loss) On Sale Of Investments

—

—

—

—

1,241

-1,662

-610

-657

-167

-385

Asset Writedown

—

—

—

—

—

—

—

—

—

—

In Process R&D Expenses

—

—

—

—

-5,051

-5,968

-939

-3,644

-1,205

-7,087

Legal Settlements

—

—

—

—

—

—

—

-1,075

—

-525

-525

Other Unusual Items

—

—

—

—

—

—

—

—

21

60

76

EBT, Incl. Unusual Items

5,160

1,669

8,278

5,814

6,860

1,539

Income Tax Expense

-204

1,580

2,077

1,248

1,247

505

Earnings From Continuing Operations

5,364

89

6,201

4,566

5,613

1,034

Minority Interest

22

34

24

26

52

20

Net Income

5,386

123

6,225

4,592

5,665

1,054

Net Income to Common Incl Extra Items

5,386

123

6,225

4,592

5,665

1,054

Net Income to Common Excl. Extra Items

5,386

123

6,225

4,592

5,665

1,054

Total Shares Outstanding

1,266

1,254

1,254

1,247

1,246

1,246

Weighted Avg. Shares Outstanding

1,270

1,257

1,256

1,255

1,248

1,247

Weighted Avg. Shares Outstanding Dil

1,277

1,263

1,262

1,262

1,258

1,251.5

EPS

4.2

0.1

5

3.7

4.5

0.8

EPS Diluted

4.2

0.1

4.9

3.6

4.5

0.8

EBITDA

10,742

12,439

13,982

13,056

12,495

13,462

Effective Tax Rate

-4%

94.7%

25.1%

21.5%

18.2%

32.8%